Clinical pharmacology of daunorubicin in phase I patients with solid tumors: development of an analytical methodology for daunorubicin and its metabolites.

Google Scholar
  • 1 December 1984
    • journal article
    • Vol. 11, 36-44
Abstract
No abstract available